ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth $400 million. More
Articles
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 129 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. More
SOFI Stock: The Analyst Call Giving SoFi Technologies Investors Something to Smile About Today
One Morgan Stanley analyst thinks the future is bright for Sofi Technologies. And as a result, SOFI stock is reacting well so far. More
Novavax Stock Got Merck-ed, but Don’t Dump Your Shares Now
NVAX stock still has plenty of value as Novavax has a rich and diverse clinical pipeline, including a promising influenza vaccine candidate. More
It’s Time to Rock and Roll with Rocket Companies Stock
Maybe you never expected Rocket Companies to venture into the solar panel market, but some nice surprises are in store for RKT stock holders. More
